Search
Close this search box.

Clinical Trial: ECOG-ACRIN EA3161

ECOG-ACRIN EA3161

Status: Open

A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC

EA3161 will temporarily close to accrual to explore possibility to increase accrual goal effective July 22, 2024.